The inaugural Portfolio Strategy & Decision Making for Biopharma Summit was a must-attend event for leaders in the pharma and biotech industries who are aiming to refine their portfolio strategies. This summit offered unique insights into leveraging advanced data analytics and forecasting tools to make better decisions to navigate the volatile biopharma market.
Attendees had the exclusive opportunity to network with industry leaders and learn from detailed case studies, best practices, and innovative approaches from both experienced big pharma and agile biotechs. The event focused on enhancing cross-functional collaboration and leveraging partnership opportunities.
As the biopharma market faces unprecedented challenges and rapid changes, attending this summit was crucial for staying ahead. By joining us the attendees had the chance to make informed decisions, mitigate risks, align stakeholders, and drive sustainable portfolio growth.
Analyse, Adapt, Respond & Implement to Mitigate Portfolio Risk!
Who Booked On:
2024 World-Class Speaker Faculty
Networking Opportunities
Our attendees connected with pharma and biotech leaders including Gilead, GSK, the NCI, Novartis, and Novo Nordisk and took advantage of the exclusive opportunity to share knowledge, build professional relationships, and form strategic partnerships that enhance your approach to portfolio strategy. Networking opportunities included:
Breakfast Briefing: This session offered an excellent opportunity to engage in deep-dive discussions, participate in an interactive Q&A, and network with senior leaders and experts in a relaxed, informal setting
Networking Breaks: These are the ideal opportunities to meet fellow industry leaders face-to-face and make new connections
Panel Discussions: These provided a platform for attendees to connect with other professionals and experts in the field, leading to valuable collaborations and future learning experiences
Hear From Our Previous Speakers
“I look forward to speaking at the summit because I appreciate the opportunity to showcase what I've learned in my journey and will learn from others in the industry during this summit, where I've succeeded and failed, and why I feel empowered in my mission of advancing data strategy."
- Richard Van, Healthcare Innovation & Strategy Lead, US Immunology at UCB
"It is important (and fun!) to connect with the community to share knowledge as well as hear and learn from others who have similar or different experiences. After participating in a summit, I often leave feeling inspired and energized by the experience.”
- Sarah Hudson, Senior Director, Portfolio Strategy & Program Management at Avidity Biosciences
"Bringing together the best in field, this meeting is an excellent opportunity to share, learn, and foster best practices in portfolio strategy and decision-making."
- Satinder Rawat PhD, MBA, Corporate Strategy & Business Development Advisor, Independent Consultant
Previous Expert Speakers Included:
Previous Partners:
